1. Home
  2. MAIA vs FLNT Comparison

MAIA vs FLNT Comparison

Compare MAIA & FLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • FLNT
  • Stock Information
  • Founded
  • MAIA 2018
  • FLNT 2001
  • Country
  • MAIA United States
  • FLNT United States
  • Employees
  • MAIA N/A
  • FLNT N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • FLNT Advertising
  • Sector
  • MAIA Health Care
  • FLNT Consumer Discretionary
  • Exchange
  • MAIA Nasdaq
  • FLNT Nasdaq
  • Market Cap
  • MAIA 46.7M
  • FLNT 39.2M
  • IPO Year
  • MAIA 2022
  • FLNT N/A
  • Fundamental
  • Price
  • MAIA $1.74
  • FLNT $1.94
  • Analyst Decision
  • MAIA
  • FLNT Hold
  • Analyst Count
  • MAIA 0
  • FLNT 1
  • Target Price
  • MAIA N/A
  • FLNT $3.00
  • AVG Volume (30 Days)
  • MAIA 417.6K
  • FLNT 13.6K
  • Earning Date
  • MAIA 08-08-2025
  • FLNT 08-18-2025
  • Dividend Yield
  • MAIA N/A
  • FLNT N/A
  • EPS Growth
  • MAIA N/A
  • FLNT N/A
  • EPS
  • MAIA N/A
  • FLNT N/A
  • Revenue
  • MAIA N/A
  • FLNT $243,850,000.00
  • Revenue This Year
  • MAIA N/A
  • FLNT N/A
  • Revenue Next Year
  • MAIA N/A
  • FLNT $11.62
  • P/E Ratio
  • MAIA N/A
  • FLNT N/A
  • Revenue Growth
  • MAIA N/A
  • FLNT N/A
  • 52 Week Low
  • MAIA $1.40
  • FLNT $1.50
  • 52 Week High
  • MAIA $4.24
  • FLNT $3.83
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 47.75
  • FLNT 50.66
  • Support Level
  • MAIA $1.66
  • FLNT $1.78
  • Resistance Level
  • MAIA $1.95
  • FLNT $1.94
  • Average True Range (ATR)
  • MAIA 0.12
  • FLNT 0.10
  • MACD
  • MAIA -0.00
  • FLNT 0.02
  • Stochastic Oscillator
  • MAIA 31.82
  • FLNT 70.37

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About FLNT Fluent Inc.

Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.

Share on Social Networks: